Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Healthier Choices Management Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
10.6
13
14.6
15.1
13.9
13.3
29.3
0
0
0
Cost of revenue
0
0.07
0.03
Gross profit
5.23
6.27
7.16
6.48
5.78
5.29
10.2
-0
-0.07
-0.03
Selling, general and administrative
9.7
16.4
9.95
10.4
8.84
10
18.9
32.2
General and administrative
1
1
Operating expenses
14.1
16.6
10.1
10.9
9.23
10
18.9
7.45
8.44
7.01
Operating income
-8.86
-10.3
-2.98
-4.41
-3.45
-4.74
-8.65
-7.45
-8.5
-7.03
Interest expense
0.02
0.01
0.01
0.04
0.27
0.07
Interest income
0.05
0.03
0.11
0.11
0.04
0.06
0.06
0.18
Other non-operating income
21.1
0.13
-10.2
1.61
-0.27
0.7
1.44
-1.1
0.39
0.02
Income tax
0
0
0
0
0
Income from continuing operations
12.3
-10.2
-13.2
-8.55
-8.12
-7.02
Net income
10.7
-9.87
-13.2
-2.8
-3.72
-4.04
-7.22
-18.5
-11.9
-7.02
EBITDA
-8.49
-9.94
-2.61
-3.82
-2.9
-4.24
-7.59
-5.96
-8.44
-6.99
EPS, basic
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EPS, diluted
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Shares, basic (weighted)
4,103
26,200
42,697
66,978
90,352
307,913
339,742
429,919
479,696
481,267
Shares, diluted (weighted)
640,656
26,200
42,697
66,978
90,352
307,913
339,742
429,919
479,696
481,267
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
13.4
7.88
7.06
1.53
0.93
26.5
24.7
3.66
1.19
1.14
Short-term investments
0.09
0.02
0.02
0.02
0.01
Receivables
0.03
0.08
0.07
0.07
0.02
0.03
0.06
0.13
0
Inventory
0.75
0.86
1.86
1.76
1.75
1.52
3.82
0.07
0.04
0.04
Other current assets
0.09
0.04
0.4
0
1.23
0.01
Total current assets
14.3
8.95
9.5
3.64
3.01
28.8
30.3
11.7
1.95
1.34
Property, plant and equipment
0.64
0.59
0.5
0.33
0.23
0.18
3.11
0.06
0.08
0.01
Lease right-of-use assets
0
4.66
4.08
3.54
10.6
0.1
0
0
Goodwill
0.48
0.48
1.44
0.96
0.92
0.92
5.75
Intangible assets
1.67
1.56
3.06
1.92
1.25
0.95
5.01
0.2
0.16
0.12
Other non-current assets
0.13
0.12
0.14
0.15
0.09
0.09
0.48
0.15
0.03
Total assets
17.2
11.7
15.2
14
11.9
34.4
55.3
31
2.22
1.47
Accounts payable
0.52
0.51
1.3
0.83
1.09
1.64
5.72
3.1
2.02
1.59
Accrued liabilities
0.78
0.44
1.5
Deferred revenue
0.44
0.03
0.02
0.02
0.2
0.21
Short-term debt
0
0.54
1.16
Total current liabilities
14.8
11.2
5.62
3.69
5.65
2.52
9.91
12.2
2.67
1.59
Long-term debt
0.01
0
2.38
2.4
Lease liabilities
0
3.54
3.11
2.69
8.04
0
0
Other non-current liabilities
3.75
Total liabilities
14.8
11.3
6.75
8.1
9.62
5.21
20.3
23.1
2.67
1.59
Total debt
0.01
1.4
4.92
0
2.91
3.56
Paid-in capital
3.78
10.1
7.35
7.62
3.96
30.9
29
21
25.3
28.3
Retained earnings
-2.75
-12.6
-25.7
-28.6
-32.4
-36.4
-43.6
-62.1
-75
-82.1
Shareholders' equity
2.51
0.44
8.43
5.9
2.26
29.2
20.2
6.76
-1.56
-1.23
Total equity
2.51
0.44
8.43
5.9
2.26
29.2
20.2
6.76
-1.56
-1.23
Total liabilities and equity
17.2
11.7
15.2
14
11.9
34.4
55.3
31
2.22
1.47
Shares outstanding
14,214
29,349
66,624
67,698
143,841
339,742
339,742
478,267
481,267
525,156
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
10.7
-9.87
-13.2
-2.8
-3.72
-4.04
-7.22
-18.5
-11.9
-7.02
Depreciation and amortization
0.37
0.35
0.38
0.59
0.55
0.5
1.06
1.49
0.07
0.05
Stock-based compensation
0.08
7.5
1.71
0.37
0.08
0.03
0.07
3.43
4.62
3.4
Change in receivables
-0.2
-0.04
0.04
0.03
0.04
-0
-0.03
-0.09
-0.25
-0
Change in inventory
-0.35
-0.51
-0.25
0.11
-0.33
-0.48
-1.36
-2.03
0.09
-0.01
Change in payables
0.33
-0.26
0.35
-0.48
0.27
0.56
4.07
1.97
-1.08
-0.43
Cash from operations
-7.32
-2.82
-0.14
-3.54
-2.28
-3.53
-3.87
-4.74
-3.66
-3.88
Capital expenditures
-0.03
-0.14
-0.08
-0.03
-0.02
-0.06
-0.48
-0.18
-0.05
Acquisitions
-2.91
0
-0.08
-10.3
-0.75
-5.48
Cash from investing
-3.19
-0.19
-4.02
0.13
-0.08
-0.09
-10.7
-0.77
-4.92
Stock issued
0
0.08
0
0
24.3
0
Cash from financing
-3.35
-2.47
3.35
-0.13
1.76
27.2
12.8
-13.5
4.69
3.37
Net change in cash
-13.8
-5.48
-0.82
-3.54
-0.6
23.6
-1.81
-19.1
-3.89
Free cash flow
-7.34
-2.97
-0.22
-3.57
-2.31
-3.58
-4.35
-4.92
-3.7
Interest paid
0.02
0
0.01
0.14
0.31
0.12
0.04
0.21
0.02
0
Income taxes paid
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-237.8%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
494.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-95.3%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-81.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-33.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-70.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-34.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
12.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
39.7%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.66x
Current assets / current liabilities.
Quick ratio
0.56x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.56x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
Earnings yield
-6.7%
Net income / market cap (the inverse of P/E).
What was Healthier Choices Management Corp.'s revenue in fiscal 2025?
Healthier Choices Management Corp. reported revenue of $3.0K for fiscal 2025, 494.6% higher than the year before.
Was Healthier Choices Management Corp. profitable in fiscal 2025?
No. It reported a net loss of $7.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.